Johnson & Johnson To Pay More Than $1.6 Billion To Resolve Healthcare Fraud Allegations

Monday, November 4, 2013

Tennessee will receive more than $12 million as part of a multistate and federal agreement resolving allegations pharmaceutical manufacturer Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, Inc., used deceptive marketing tactics. Specifically, the parties will pay $1.6 billion to resolve civil and criminal allegations of unlawful marketing practices to promote the sales of their atypical antipsychotic drugs, Risperdal and Invega. 

J&J and Janssen will pay in excess of $1.2 billion to the states and the federal government to resolve four qui tam, or whistleblower, lawsuits filed in the U.S. District Court for the Eastern District of Pennsylvania under the provisions of the federal False Claims Act and similar state False Claims statutes. In addition, Janssen Pharmaceuticals, Inc. will plead guilty in federal court to a criminal misdemeanor charge of misbranding Risperdal in violation of the Food, Drug, and Cosmetic Act.  As part of the criminal plea, Janssen has agreed to pay an additional $400 million in criminal fines and forfeitures.

“We applaud the cooperative work of the states and federal government to stop drug companies from illegally marketing potentially dangerous drugs to the public,” Tennessee Attorney General Bob Cooper said.  “The public needs to be able to trust those responsible for their health and well-being, and that includes drug manufacturers and those who prescribe medications.” 

J & J and Janssen allegedly promoted, marketed and introduced Risperdal and Invega into interstate commerce for uses not approved by the Food and Drug Administration and for uses that were not medically indicated.  Once the FDA approves a drug as safe and effective, a manufacturer cannot market or promote a drug for an “off-label” or other use not identified in the FDA-approved product label.  The states contend that during the period Jan. 1, 1999 through Dec. 31, 2005, the companies promoted Risperdal for off-label uses and made false and misleading statements about the safety and efficacy of Risperdal.

The states additionally allege J&J and Janssen paid illegal kickbacks to health care professionals and long-term care pharmacy providers to induce them to promote or prescribe Risperdal to children, adolescents and the elderly when there was no FDA approval for Risperdal use in these patient populations. The states further contend that from Jan. 1, 2007 through Dec. 31, 2009, the companies promoted Invega for off-label uses and made false and misleading statements about the safety and efficacy of Invega.  The manufacturers’ alleged unlawful conduct caused false and/or fraudulent claims to be submitted to or caused purchases by government funded health care programs, including the state Medicaid programs. 

As part of the global resolution, the companies will enter into a Corporate Integrity Agreement with the U.S. Department of Health and Human Services, Office of the Inspector General, which will monitor the company’s future marketing practices.

A team from the National Association of Medicaid Fraud Control Units worked with the federal government on the investigation and conducted the settlement negotiations with the pharmaceutical manufacturers on behalf of the states.  Team members included representatives from the Offices of the Attorneys General for the states of New York, Massachusetts, Ohio and California.

Senate Health Committee To Hold Zika Hearing On Feb. 24 At 10 A.M.

Chairman Lamar Alexander and Ranking Member Patty Murray (D-Wash.) announced Thursday the Senate committee overseeing public health policy will hold a hearing on the Zika virus on Wednesday, Feb. 24, at 10 a.m. Chairman Alexander said: “Americans have many questions about the Zika virus, as we have watched news of its spread through Central and South America, as well as ... (click for more)

Dade County And The Arts - Dancing With Breast Cancer

In 2006, I was diagnosed with breast cancer and had bi-lateral mastectomies. Now, almost 10 years later, I look back at how dance and art transformed my life-challenging situation into beauty. With the help and support of my friend and artist Mary Petruska, I decided not to do reconstruction. From a beautiful drawing of wild passion flowers by Mary, we went to tattoo artist Skip ... (click for more)

Underground Fire Closes Several Downtown Streets

An underground fire closed severqal downtown streets late Sunday afternoon. At approximately 5:20 p.m.,  t he Chattanooga Fire Department responded to a reported fire in a man-hole at the corner of Chestnut Street and W. 8th Street. When fire companies arrived on the scene, they  found black smoke coming from an underground electrical service line.  The ... (click for more)

16-Year-Old Who Was Shot In The Head In East Ridge Dies

 Monserrate Ferrer, the 16 year old who  was shot in East Ridge on Friday , has died. Investigators will meet early next week with the Hamilton County District  Attorney's Office to discuss the case. The shooting that involved two juveniles was at the 4200 block of Bennett Road. Responding officers found a 16-year-old boy in the bedroom with a single ... (click for more)

Donna Horn: I'm Not A Good Ole Boy

Roy Exum continues to reload his poisonous pen.  Yesterday he wrote some untruths about me and some of the other board members that just happen to be educators as well.   For the record, one cannot run for school board if one is a teacher at the time of the election.   He said that I was still teaching when I was on the school board-not possible.  I retired in ... (click for more)

Roy Exum: Vote ‘No’ On Vouchers

I fully believe that public education in Hamilton County is the single most important opportunity that challenges us today. Over the weekend the new website for the ‘Chattanooga 2.0’ initiative went up and every parent who has a child in our public system should make it “required reading.” You can find it at www.chatt2.org. Please sign up for updates because a lot of us need to ... (click for more)